Theravance Biopharma, Inc. - Ordinary Shares (TBPH) SEC filings
TBPH SEC filings moved a median of +0.14% by the close. TBPH SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TBPH overview →
60 measured TBPH SEC filing events.
Where these TBPH SEC filings landedvs 55 measured TBPH SEC filing reactions
| Middle 50% of TBPH SEC filing reactions | -1.00% to +1.27% |
|---|---|
| Median reaction (to close) | +0.14% |
| Measured reactions | 55 |
Point-in-time · zero look-ahead
Half of the 55 TBPH SEC filing events with a measured close landed between -1.00% and +1.27%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Theravance Biopharma, | SEC filing · Form 15-12G | — | — | |
| Form S-8 POS Theravance Biopharma, | SEC filing · Form S-8 | — | — | |
| Form 8-K Theravance Biopharma, For: Sep 23 | SEC filing · Form 8-K | — | — | |
| Form 8-K Theravance Biopharma, For: Sep 18 | SEC filing · Form 8-K | +0.00% | +0.12% | |
| Form 8-K Theravance Biopharma, For: Sep 10 | SEC filing · Form 8-K | -0.29% | -0.18% | |
| Form 8-K Theravance Biopharma, For: Aug 25 | SEC filing · Form 8-K | +0.00% | -0.12% | |
| Form DEFA14A Theravance Biopharma, | SEC filing · Form DEFA14A | +0.00% | -0.12% | |
| Form DEFM14A Theravance Biopharma, | SEC filing · Form DEFM14A | +0.06% | +0.24% | |
| Form 10-Q Theravance Biopharma, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.06% | |
| Form PREM14A Theravance Biopharma, For: Aug 11 | SEC filing · Form PREM14A | +0.00% | +0.06% | |
| Form 8-K Theravance Biopharma, For: Aug 10 | SEC filing · Form 8-K | +0.06% | — | |
| Form 8-K Theravance Biopharma, For: Jun 28 | SEC filing · Form 8-K | +0.06% | +0.53% | |
| Form DEFA14A Theravance Biopharma, | SEC filing · Form DEFA14A | +0.06% | +0.53% | |
| Form 8-K Theravance Biopharma, For: Jun 19 | SEC filing · Form 8-K | +0.64% | +1.17% | |
| Form 8-K Theravance Biopharma, For: Jun 12 | SEC filing · Form 8-K | -0.75% | -1.75% | |
| Form 10-Q Theravance Biopharma, For: Mar 31 | SEC filing · Form 10-Q | +0.33% | +0.47% | |
| Form 8-K Theravance Biopharma, For: May 07 | SEC filing · Form 8-K | +0.33% | +0.47% | |
| Form DEF 14A Theravance Biopharma, For: Jun 12 | SEC filing · Form DEF | -0.27% | +0.54% | |
| Form 8-K Theravance Biopharma, For: Mar 27 | SEC filing · Form 8-K | +0.65% | +5.39% | |
| Form 10-K Theravance Biopharma, For: Dec 31 | SEC filing · Form 10-K | -0.03% | +0.14% | |
| Form 8-K Theravance Biopharma, For: Mar 19 | SEC filing · Form 8-K | +0.64% | +2.86% | |
| Form 8-K Theravance Biopharma, For: Mar 03 | SEC filing · Form 8-K | -4.31% | -0.50% | |
| Form 8-K Theravance Biopharma, For: Jan 12 | SEC filing · Form 8-K | -1.05% | +3.31% | |
| Form 8-K Theravance Biopharma, For: Dec 08 | SEC filing · Form 8-K | -0.54% | -3.10% | |
| Form 10-Q Theravance Biopharma, For: Sep 30 | SEC filing · Form 10-Q | -1.69% | — | |
| Form 8-K Theravance Biopharma, For: Nov 10 | SEC filing · Form 8-K | +10.02% | +18.82% | |
| Form 8-K Theravance Biopharma, For: Aug 25 | SEC filing · Form 8-K | +1.07% | -1.81% | |
| Form 8-K Theravance Biopharma, For: Aug 15 | SEC filing · Form 8-K | -0.30% | -0.81% | |
| Form 10-Q Theravance Biopharma, For: Jun 30 | SEC filing · Form 10-Q | +0.84% | +4.19% | |
| Form 8-K Theravance Biopharma, For: Aug 12 | SEC filing · Form 8-K | +4.25% | +3.59% | |
| Form 8-K Theravance Biopharma, For: Jun 10 | SEC filing · Form 8-K | +0.37% | +0.28% | |
| Form 8-K Theravance Biopharma, For: Jun 05 | SEC filing · Form 8-K | +1.10% | +2.93% | |
| Form 8-K Theravance Biopharma, For: May 30 | SEC filing · Form 8-K | +4.20% | +11.50% | |
| Form 8-K Theravance Biopharma, For: May 19 | SEC filing · Form 8-K | +0.00% | +0.43% | |
| Form 10-Q Theravance Biopharma, For: Mar 31 | SEC filing · Form 10-Q | -0.90% | +0.34% | |
| Form 8-K Theravance Biopharma, For: May 08 | SEC filing · Form 8-K | +1.28% | +0.00% | |
| Form DEF 14A Theravance Biopharma, For: May 19 | SEC filing · Form DEF | -1.91% | +0.12% | |
| Form 10-K Theravance Biopharma, For: Dec 31 | SEC filing · Form 10-K | -0.31% | -1.14% | |
| Form 8-K Theravance Biopharma, For: Feb 26 | SEC filing · Form 8-K | +2.02% | -6.17% | |
| Form 10-Q Theravance Biopharma, For: Sep 30 | SEC filing · Form 10-Q | +0.10% | -1.03% | |
| Form 8-K Theravance Biopharma, For: Nov 12 | SEC filing · Form 8-K | +3.17% | +2.22% | |
| Form 8-K Theravance Biopharma, For: Sep 18 | SEC filing · Form 8-K | -0.37% | -1.61% | |
| Form 8-K Theravance Biopharma, For: Sep 10 | SEC filing · Form 8-K | +0.31% | +1.37% | |
| Form 10-Q Theravance Biopharma, For: Jun 30 | SEC filing · Form 10-Q | -0.65% | -1.16% | |
| Form 8-K Theravance Biopharma, For: Aug 05 | SEC filing · Form 8-K | -5.55% | -9.48% | |
| Form 10-Q Theravance Biopharma, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.47% | |
| Form 8-K Theravance Biopharma, For: May 13 | SEC filing · Form 8-K | -3.49% | -3.59% | |
| Form 8-K Theravance Biopharma, For: May 08 | SEC filing · Form 8-K | -0.85% | -0.74% | |
| Form DEF 14A Theravance Biopharma, For: May 08 | SEC filing · Form DEF | -0.65% | +1.94% | |
| Form 10-K Theravance Biopharma, For: Dec 31 | SEC filing · Form 10-K | -1.38% | -3.19% | |
| Form 8-K Theravance Biopharma, For: Feb 28 | SEC filing · Form 8-K | -0.21% | -0.53% | |
| Form 8-K Theravance Biopharma, For: Feb 26 | SEC filing · Form 8-K | -0.48% | +4.31% | |
| Form 8-K Theravance Biopharma, For: Jan 12 | SEC filing · Form 8-K | -2.48% | -4.46% | |
| Form 8-K Theravance Biopharma, For: Jan 05 | SEC filing · Form 8-K | +1.37% | +1.17% | |
| Form 8-K Theravance Biopharma, For: Dec 26 | SEC filing · Form 8-K | +0.09% | -0.96% | |
| Form 8-K Theravance Biopharma, For: Dec 21 | SEC filing · Form 8-K | +0.17% | -3.83% | |
| Form DEFA14A Theravance Biopharma, | SEC filing · Form DEFA14A | +0.17% | -3.83% | |
| Form 10-Q Theravance Biopharma, For: Sep 30 | SEC filing · Form 10-Q | +0.10% | +0.60% | |
| Form 8-K Theravance Biopharma, For: Nov 07 | SEC filing · Form 8-K | +2.84% | +0.49% | |
| Form 8-K Theravance Biopharma, For: Oct 27 | SEC filing · Form 8-K | -0.75% | +1.40% |
Keep exploring
More TBPH: earnings → · analyst actions → · TBPH overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DBV Technologies S.A. - American Depositary Shares (DBVT) | 327 | -0.15% | 40% |
| Novartis AG (NVS) | 326 | +0.03% | 51% |
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
| Bionano Genomics, Inc. (BNGO) | 321 | -0.94% | 31% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.